• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For February 9, 2022

    2/9/22 10:02:30 AM ET
    $ABST
    $ACAD
    $AMD
    $ARGO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Semiconductors
    Technology
    Get the next $ABST alert in real time by email

     

    Upgrades

    • According to Capital One, the prior rating for Federal Realty Investment Trust (NYSE:FRT) was changed from Equal-Weight to Overweight. Federal Realty Investment earned $1.51 in the third quarter, compared to $1.12 in the year-ago quarter. At the moment, the stock has a 52-week-high of $140.51 and a 52-week-low of $90.16. Federal Realty Investment closed at $122.79 at the end of the last trading period.
    • Check out this: Executives Buy Around $64M Of 3 Stocks
    • According to SVB Leerink, the prior rating for Tenet Healthcare Corp (NYSE:THC) was changed from Market Perform to Outperform. In the fourth quarter, Tenet Healthcare showed an EPS of $2.70, compared to $4.72 from the year-ago quarter. The stock has a 52-week-high of $83.69 and a 52-week-low of $48.20. At the end of the last trading period, Tenet Healthcare closed at $74.07.
    • For Absolute Software Corp (NASDAQ:ABST), TD Securities upgraded the previous rating of Hold to Buy. Absolute Software earned $0.13 in the second quarter, compared to $0.04 in the year-ago quarter. The stock has a 52-week-high of $21.20 and a 52-week-low of $7.22. At the end of the last trading period, Absolute Software closed at $8.03.
    • For Enphase Energy Inc (NASDAQ:ENPH), Craig-Hallum upgraded the previous rating of Hold to Buy. In the fourth quarter, Enphase Energy showed an EPS of $0.73, compared to $0.51 from the year-ago quarter. The current stock performance of Enphase Energy shows a 52-week-high of $282.46 and a 52-week-low of $108.88. Moreover, at the end of the last trading period, the closing price was at $144.50.
    • HC Wainwright & Co. upgraded the previous rating for ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) from Neutral to Buy. In the third quarter, ACADIA Pharmaceuticals showed an EPS of $0.09, compared to $0.54 from the year-ago quarter. The current stock performance of ACADIA Pharmaceuticals shows a 52-week-high of $52.80 and a 52-week-low of $15.68. Moreover, at the end of the last trading period, the closing price was at $25.13.
    • For Advanced Micro Devices Inc (NASDAQ:AMD), Daiwa Capital upgraded the previous rating of Outperform to Buy. For the fourth quarter, Advanced Micro Devices had an EPS of $0.92, compared to year-ago quarter EPS of $0.52. The current stock performance of Advanced Micro Devices shows a 52-week-high of $164.46 and a 52-week-low of $72.50. Moreover, at the end of the last trading period, the closing price was at $128.23.
    • Susquehanna upgraded the previous rating for Penn National Gaming Inc (NASDAQ:PENN) from Neutral to Positive. Penn National Gaming earned $0.26 in the fourth quarter, compared to $0.08 in the year-ago quarter. The stock has a 52-week-high of $142.00 and a 52-week-low of $37.76. At the end of the last trading period, Penn National Gaming closed at $48.11.
    • Morgan Stanley upgraded the previous rating for GDS Holdings Ltd (NASDAQ:GDS) from Equal-Weight to Overweight. GDS Holdings earned $0.29 in the third quarter, compared to $0.21 in the year-ago quarter. The current stock performance of GDS Holdings shows a 52-week-high of $116.76 and a 52-week-low of $34.95. Moreover, at the end of the last trading period, the closing price was at $38.98.
    • According to JP Morgan, the prior rating for Karyopharm Therapeutics Inc (NASDAQ:KPTI) was changed from Underweight to Neutral. For the fourth quarter, Karyopharm Therapeutics had an EPS of $0.46, compared to year-ago quarter EPS of $0.59. At the moment, the stock has a 52-week-high of $17.39 and a 52-week-low of $4.42. Karyopharm Therapeutics closed at $8.19 at the end of the last trading period.
    • For Thomson Reuters Corp (NYSE:TRI), RBC Capital upgraded the previous rating of Sector Perform to Outperform. Thomson Reuters earned $0.43 in the fourth quarter, compared to $0.54 in the year-ago quarter. The stock has a 52-week-high of $123.60 and a 52-week-low of $80.16. At the end of the last trading period, Thomson Reuters closed at $103.16.

    See all analyst ratings upgrades.

     

    Downgrades

    • Lake Street downgraded the previous rating for QuinStreet Inc (NASDAQ:QNST) from Buy to Hold. In the second quarter, QuinStreet showed an EPS of $0.06, compared to $0.13 from the year-ago quarter. The stock has a 52-week-high of $25.26 and a 52-week-low of $13.23. At the end of the last trading period, QuinStreet closed at $15.57.
    • For General Motors Co (NYSE:GM), Nomura Instinet downgraded the previous rating of Buy to Neutral. For the fourth quarter, General Motors had an EPS of $1.35, compared to year-ago quarter EPS of $2.52. The stock has a 52-week-high of $67.21 and a 52-week-low of $47.07. At the end of the last trading period, General Motors closed at $49.46.
    • For Willis Towers Watson PLC (NASDAQ:WTW), Wells Fargo downgraded the previous rating of Overweight to Equal-Weight. Willis Towers Watson earned $5.67 in the fourth quarter, compared to $5.23 in the year-ago quarter. The stock has a 52-week-high of $240.34 and a 52-week-low of $217.00. At the end of the last trading period, Willis Towers Watson closed at $225.14.
    • According to SVB Leerink, the prior rating for Incyte Corp (NASDAQ:INCY) was changed from Market Perform to Underperform. Incyte earned $0.10 in the fourth quarter, compared to $0.93 in the year-ago quarter. At the moment, the stock has a 52-week-high of $94.50 and a 52-week-low of $61.91. Incyte closed at $70.07 at the end of the last trading period.
    • According to JP Morgan, the prior rating for Big Lots Inc (NYSE:BIG) was changed from Neutral to Underweight. Big Lots earned $0.14 in the third quarter, compared to $0.76 in the year-ago quarter. At the moment, the stock has a 52-week-high of $73.23 and a 52-week-low of $38.44. Big Lots closed at $39.45 at the end of the last trading period.

    See all analyst ratings downgrades.

     

    Initiations

    • Maxim Group initiated coverage on SeqLL Inc (NASDAQ:SQL) with a Buy rating. The price target for SeqLL is set to $3.00. The current stock performance of SeqLL shows a 52-week-high of $5.80 and a 52-week-low of $1.26. Moreover, at the end of the last trading period, the closing price was at $1.60.
    • JPWith a Buy rating, Deutsche Bank initiated coverage on R1 RCM Inc (NASDAQ:RCM). The price target seems to have been set at $30.00 for R1 RCM. In the third quarter, R1 RCM showed an EPS of $0.05, compared to $0.00 from the year-ago quarter. The stock has a 52-week-high of $31.28 and a 52-week-low of $18.71. At the end of the last trading period, R1 RCM closed at $24.45.
    • With a Buy rating, B of A Securities initiated coverage on Veritone Inc (NASDAQ:VERI). The price target seems to have been set at $22.00 for Veritone. Veritone earned $0.07 in the third quarter, compared to $0.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $50.34 and a 52-week-low of $13.06. Veritone closed at $17.70 at the end of the last trading period.
    • With a Buy rating, EF Hutton initiated coverage on Hour Loop Inc (NASDAQ:HOUR). The price target seems to have been set at $7.00 for Hour Loop. At the moment, the stock has a 52-week-high of $10.33 and a 52-week-low of $2.41. Hour Loop closed at $2.55 at the end of the last trading period.
    • With an Overweight rating, Morgan Stanley initiated coverage on Safehold Inc (NYSE:SAFE). The price target seems to have been set at $150.00 for Safehold. In the third quarter, Safehold showed an EPS of $0.38, compared to $0.28 from the year-ago quarter. The stock has a 52-week-high of $95.29 and a 52-week-low of $56.33. At the end of the last trading period, Safehold closed at $60.28.
    • Needham initiated coverage on Verano Holdings Corp (OTC:VRNOF) with a Buy rating. The price target for Verano Holdings is set to $26.00. The stock has a 52-week-high of $28.00 and a 52-week-low of $9.86. At the end of the last trading period, Verano Holdings closed at $11.56.
    • Keybanc initiated coverage on Constellation Energy Corp (NASDAQ:CEG) with an Overweight rating. The price target for Constellation Energy is set to $51.00. At the moment, the stock has a 52-week-high of $56.57 and a 52-week-low of $44.17. Constellation Energy closed at $45.50 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $ABST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABST
    $ACAD
    $AMD
    $ARGO

    CompanyDatePrice TargetRatingAnalyst
    Advanced Micro Devices Inc.
    $AMD
    2/13/2026$220.00Neutral
    DA Davidson
    Thomson Reuters Corporation
    $TRI
    2/10/2026$126.00Sector Perform → Outperform
    RBC Capital Mkts
    TPG Inc.
    $TPG
    2/9/2026$75.00Mkt Perform → Mkt Outperform
    Citizens
    Karyopharm Therapeutics Inc.
    $KPTI
    2/5/2026Overweight
    Cantor Fitzgerald
    Incyte Corp.
    $INCY
    2/5/2026$135.00Buy
    H.C. Wainwright
    Enphase Energy Inc.
    $ENPH
    2/4/2026$52.00Hold → Buy
    HSBC Securities
    Enphase Energy Inc.
    $ENPH
    2/4/2026$41.00Underperform → Market Perform
    BMO Capital Markets
    Enphase Energy Inc.
    $ENPH
    2/4/2026$54.00Sector Perform → Outperform
    RBC Capital Mkts
    More analyst ratings

    $ABST
    $ACAD
    $AMD
    $ARGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DA Davidson initiated coverage on Advanced Micro Devices with a new price target

    DA Davidson initiated coverage of Advanced Micro Devices with a rating of Neutral and set a new price target of $220.00

    2/13/26 8:31:11 AM ET
    $AMD
    Semiconductors
    Technology

    Thomson Reuters upgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts upgraded Thomson Reuters from Sector Perform to Outperform and set a new price target of $126.00

    2/10/26 7:59:10 AM ET
    $TRI
    Publishing
    Consumer Discretionary

    TPG Inc. upgraded by Citizens with a new price target

    Citizens upgraded TPG Inc. from Mkt Perform to Mkt Outperform and set a new price target of $75.00

    2/9/26 6:59:24 AM ET
    $TPG
    Investment Managers
    Finance

    $ABST
    $ACAD
    $AMD
    $ARGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & GM DESG Norrod Forrest Eugene sold $4,216,969 worth of shares (19,450 units at $216.81) and exercised 8,200 shares at a strike of $34.19, decreasing direct ownership by 4% to 289,098 units (SEC Form 4)

    4 - ADVANCED MICRO DEVICES INC (0000002488) (Issuer)

    2/13/26 4:20:51 PM ET
    $AMD
    Semiconductors
    Technology

    CEO & President Wood Donald C covered exercise/tax liability with 28,211 units of Common Shares of Beneficial Interest and was granted 63,708 units of Common Shares of Beneficial Interest, increasing direct ownership by 27% to 169,080 units (SEC Form 4)

    4 - FEDERAL REALTY INVESTMENT TRUST (0000034903) (Issuer)

    2/13/26 4:12:29 PM ET
    $FRT
    Real Estate Investment Trusts
    Real Estate

    Chair, President & CEO Su Lisa T sold $26,794,875 worth of shares (125,000 units at $214.36), decreasing direct ownership by 4% to 3,152,476 units (SEC Form 4)

    4 - ADVANCED MICRO DEVICES INC (0000002488) (Issuer)

    2/13/26 4:11:43 PM ET
    $AMD
    Semiconductors
    Technology

    $ABST
    $ACAD
    $AMD
    $ARGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hammond Michael P. bought $67,205 worth of Ordinary Shares (241 units at $278.86), increasing direct ownership by 11% to 2,505 units (SEC Form 4)

    4 - WILLIS TOWERS WATSON PLC (0001140536) (Issuer)

    2/13/26 4:01:10 PM ET
    $WTW
    Specialty Insurers
    Finance

    President & CEO Kothandaraman Badrinarayanan bought $259,884 worth of shares (5,000 units at $51.98) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/5/26 4:41:25 PM ET
    $ENPH
    Semiconductors
    Technology

    EVP and CFO Hendrix Felicia bought $100,874 worth of shares (7,315 units at $13.79), increasing direct ownership by 7% to 119,448 units (SEC Form 4)

    4 - PENN Entertainment, Inc. (0000921738) (Issuer)

    11/24/25 9:00:12 AM ET
    $PENN
    Hotels/Resorts
    Consumer Discretionary

    $ABST
    $ACAD
    $AMD
    $ARGO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Federal Realty Investment Trust Reports Fourth Quarter and Full Year 2025 Results

    NORTH BETHESDA, Md., Feb. 12, 2026 /PRNewswire/ -- Federal Realty Investment Trust (NYSE:FRT) today reported its results for the fourth quarter and full year ended December 31, 2025. Net income available for common shareholders was $4.68 per diluted share for the full year 2025 and $1.48 per diluted share for the fourth quarter, compared to $3.42 and $0.75 per diluted share for the same periods in 2024, respectively. Operating income for 2025 totaled $602.2 million, with $180.7 million in the fourth quarter, compared to $472.4 million and $109.3 million, respectively, in 2024.

    2/12/26 4:05:00 PM ET
    $FRT
    Real Estate Investment Trusts
    Real Estate

    Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress

    – Top-Line Data from the Phase 3 SENTRY Trial in Myelofibrosis on Track for March 2026 – – Top-Line Data from the Phase 3 XPORT-EC-042 Trial in Endometrial Cancer on Track for Mid-2026 – – Total Revenue was $146 Million and U.S. XPOVIO® (selinexor) Net Product Revenue was $115 Million for Full Year 2025 – – Company Provides Full-Year 2026 Total Revenue Guidance of $130 Million to $150 Million Including U.S. XPOVIO Net Product Revenue Guidance of $115 Million to $130 Million – – Conference Call Scheduled for Today at 8:00 a.m. ET – NEWTON, Mass., Feb. 12, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapie

    2/12/26 7:30:00 AM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Willis: Rising threats, political evacuations and kidnap shaped the 2025 crisis management landscape

    LONDON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Incidents involving threats to individuals or client assets increased by more than a third in 2025, accounting for 37% of all incidents reported to Alert:24 – the in-house risk advisory and crisis support service provided by Willis, a WTW business (NASDAQ:WTW). The second most common peril notified in its latest Crisis Management Annual Review, which was political repatriation, made up for a fifth (19%) of all 2025 incidents. 2025 was a year that continued to reshape the global risk environment. Geopolitical volatility, economic pressure, shifting alliances and the rise of youth-led activism created sustained uncertainty for organisations operatin

    2/12/26 4:00:00 AM ET
    $WTW
    Specialty Insurers
    Finance

    $ABST
    $ACAD
    $AMD
    $ARGO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for NUPLAZID issued to ACADIA PHARMS INC

    Submission status for ACADIA PHARMS INC's drug NUPLAZID (SUPPL-9) with active ingredient PIMAVANSERIN TARTRATE has changed to 'Approval' on 09/15/2023. Application Category: NDA, Application Number: 210793, Application Classification: Efficacy

    9/18/23 10:47:05 AM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NUPLAZID issued to ACADIA PHARMS INC

    Submission status for ACADIA PHARMS INC's drug NUPLAZID (SUPPL-12) with active ingredient PIMAVANSERIN TARTRATE has changed to 'Approval' on 09/15/2023. Application Category: NDA, Application Number: 207318, Application Classification: Efficacy

    9/18/23 10:40:05 AM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for DAYBUE issued to ACADIA PHARMS INC

    Submission status for ACADIA PHARMS INC's drug DAYBUE (ORIG-1) with active ingredient TROFINETIDE has changed to 'Approval' on 03/10/2023. Application Category: NDA, Application Number: 217026, Application Classification: Type 1 - New Molecular Entity

    3/13/23 10:37:07 AM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABST
    $ACAD
    $AMD
    $ARGO
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Constellation Energy Corporation

    SCHEDULE 13G/A - Constellation Energy Corp (0001868275) (Subject)

    2/13/26 4:30:00 PM ET
    $CEG
    Electric Utilities: Central
    Utilities

    SEC Form SCHEDULE 13G filed by Willis Towers Watson Public Limited Company

    SCHEDULE 13G - WILLIS TOWERS WATSON PLC (0001140536) (Subject)

    2/13/26 1:57:48 PM ET
    $WTW
    Specialty Insurers
    Finance

    SEC Form 10-K filed by Karyopharm Therapeutics Inc.

    10-K - Karyopharm Therapeutics Inc. (0001503802) (Filer)

    2/12/26 8:38:06 PM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABST
    $ACAD
    $AMD
    $ARGO
    Leadership Updates

    Live Leadership Updates

    View All

    AMD Hires Ariel Kelman as Chief Marketing Officer

    SANTA CLARA, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Today AMD (NASDAQ:AMD) announced that Ariel Kelman has been appointed Senior Vice President and Chief Marketing Officer, effective immediately. Kelman will lead the AMD global marketing organization, overseeing brand, communications, events, developer relations and go-to-market strategy. Kelman will report to Ruth Cotter, Senior Vice President and Chief Administrative Officer, and will work closely with the AMD executive team to deepen engagement with customers, partners, developers and the broader technology ecosystem as AMD continues to scale its product and solutions leadership. "Ariel is a proven marketing leader with deep experi

    2/9/26 2:00:00 PM ET
    $AMD
    Semiconductors
    Technology

    AMD Appoints KC McClure to Board of Directors

    SANTA CLARA, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- AMD (NASDAQ:AMD) today announced the appointment of KC McClure to its board of directors. McClure most recently served as a senior advisor to Accenture and was previously Chief Financial Officer of Accenture from 2019 to 2024. Throughout her more than 37-year tenure at Accenture, McClure held multiple finance and accounting leadership roles, including overseeing financial operations and investor relations. "We are delighted to welcome KC to AMD's Board of Directors," said Dr. Lisa Su, AMD chair and CEO. "KC is a proven finance leader whose operating expertise and global perspective will be an asset as we execute our strategy and exte

    1/20/26 4:15:00 PM ET
    $AMD
    Semiconductors
    Technology

    WTW appoints Health & Benefits leader for North America

    NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- WTW (NASDAQ:WTW), a leading global advisory, broking and solutions company, today announced the appointment of Sheila Nordquist as Health and Benefits (H&B) leader for North America within its Health, Wealth & Career segment, effective January 12. Nordquist will work to develop and drive the growth strategy for the business in the region. "We're pleased to appoint Sheila as our North America leader," said Anne Pullum, global leader, H&B. "With an innovative outlook on the market and a deep understanding of our business, she is well-positioned to drive growth while remaining dedicated to clients' needs. Her focus on turning priorities into action

    1/8/26 12:30:00 PM ET
    $WTW
    Specialty Insurers
    Finance

    $ABST
    $ACAD
    $AMD
    $ARGO
    Financials

    Live finance-specific insights

    View All

    Federal Realty Investment Trust Reports Fourth Quarter and Full Year 2025 Results

    NORTH BETHESDA, Md., Feb. 12, 2026 /PRNewswire/ -- Federal Realty Investment Trust (NYSE:FRT) today reported its results for the fourth quarter and full year ended December 31, 2025. Net income available for common shareholders was $4.68 per diluted share for the full year 2025 and $1.48 per diluted share for the fourth quarter, compared to $3.42 and $0.75 per diluted share for the same periods in 2024, respectively. Operating income for 2025 totaled $602.2 million, with $180.7 million in the fourth quarter, compared to $472.4 million and $109.3 million, respectively, in 2024.

    2/12/26 4:05:00 PM ET
    $FRT
    Real Estate Investment Trusts
    Real Estate

    Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress

    – Top-Line Data from the Phase 3 SENTRY Trial in Myelofibrosis on Track for March 2026 – – Top-Line Data from the Phase 3 XPORT-EC-042 Trial in Endometrial Cancer on Track for Mid-2026 – – Total Revenue was $146 Million and U.S. XPOVIO® (selinexor) Net Product Revenue was $115 Million for Full Year 2025 – – Company Provides Full-Year 2026 Total Revenue Guidance of $130 Million to $150 Million Including U.S. XPOVIO Net Product Revenue Guidance of $115 Million to $130 Million – – Conference Call Scheduled for Today at 8:00 a.m. ET – NEWTON, Mass., Feb. 12, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapie

    2/12/26 7:30:00 AM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Safehold Reports Fourth Quarter and Fiscal Year 2025 Results

    NEW YORK, Feb. 11, 2026 /PRNewswire/ -- Safehold Inc. (NYSE:SAFE) reported results for the fourth quarter and fiscal year ended December 31, 2025. SAFE published a presentation detailing these results which can be found on its website, www.safeholdinc.com in the "Investors" section. Highlights from the earnings announcement include: Q4'25 revenue was $97.9 million, and FY'25 was $385.6 millionQ4'25 net income attributable to common shareholders was $27.9 million, or $30.1 million excluding non-recurring losses, and FY'25 net income attributable to common shareholders was $114.

    2/11/26 4:05:00 PM ET
    $SAFE
    Real Estate Investment Trusts
    Real Estate

    $ABST
    $ACAD
    $AMD
    $ARGO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MP Materials Corp.

    SC 13D/A - MP Materials Corp. / DE (0001801368) (Subject)

    12/4/24 7:57:02 PM ET
    $MP
    Metal Mining
    Basic Materials

    Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

    SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

    11/22/24 4:06:56 PM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

    SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

    11/19/24 4:36:38 PM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary